Low methoxy pectins (degree of esterification (DE) Ͻ50%) readily form gels in dilute aqueous solution (1.0-2.0% (w/v)) in the presence of free Ca 2ϩ ions, as a consequence of the cross-linking of the galacturonic acid chains. A model of gelation has recently been proposed 5) in which the galacturonic acid chains initially undergo strong association in the presence of calcium ions to form dimers, gelation then occurs by weak electrostatic inter-dimer association. In our formulations, gelation of the orally administered liquid formulations was ensured by the inclusion of calcium ions in the formulation as a soluble complex designed to break down to release free calcium ions on encountering the acidic environment of the stomach.
It is often necessary to include taste masking agents in oral dosage forms to disguise the bitter taste of drugs such as acetaminophen. In a recent study 4) we examined the effects of several taste masking agents including the polyhydric alcohols sorbitol, erythritol, xylitol and mannitol on the physicochemical properties and release characteristics of in situ gelling pectin formulations. Inclusion of 10% (w/v) D-sorbitol reduced the viscosity of the pectin sols and ensured Newtonian flow properties, so improving the ease of swallowing of these formulations. Pectin gels (2.0% (w/v)) containing D-sorbitol (10% (w/v)) sustained the release of acetaminophen in the rat stomach and bioavailabilities of approximately 90% of those from an orally administered acetaminophen syrup were achieved.
In healthy young Caucasians the average gastric pH is less than pH 3 during 90% of the fasted state. 6) However, at the upper limits of this pH range it is possible that the hydrogen ion concentration may not be sufficiently high to ensure adequate release of complexed calcium and hence gelation of the sols may not occur in all patients. In the present article we investigate the effects of pH change over the range 1 to 3 on the gelation and sustained release characteristics of pectin formulations in the presence and absence of the taste masking agent sorbitol.
MATERIALS AND METHODS
Chemicals Pectin (LM-104AS, DEϭ31%, Lot 23001-7) was supplied by SANSHO Co. (Osaka, Japan). Acetaminophen (paracetamol) was obtained from Astellas Pharma Inc. (Tokyo, Japan) and D-sorbitol was obtained from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). All other reagents were of analytical grade.
Preparation of Sols Pectin solutions (1.5% (w/v)) were prepared by adding the pectin to ultrapure water containing 0.5% (w/v) (19.4 mmol/l) sodium citrate and 0.1% (w/v) (9.0 mmol/l) calcium chloride and heating to 40-50°C while stirring. Appropriate amounts of acetaminophen (1.0% (w/v)) and D-sorbitol (10% (w/v)) were then dissolved in the resulting solution.
Gelation of Pectin Sols The influence of pH on the gelation characteristics of 1.5% (w/v) pectin sols was determined by immersion of 30 ml sol (with and without added D-sorbitol) enclosed in dialysis tubing (Viskase Sales Co., size 36/32) into dilute solutions of HCl (150 ml) with pH values over the range 1.0 to 3.5. After equilibration for 24 h at room temperature, the contents of the tube were passed through a Dilute solutions of pectin containing complexed calcium ions form gels when these ions are released in the acidic environment of the stomach. The aim of this study was to examine the influence of a variation of gastric pH and the addition of a taste masking agent on the gelation of the pectin solutions and on the in vitro and in vivo release of acetaminophen from the gels. Increase of pH above 2.5 and addition of 10% (w/v) D-sorbitol significantly affected the ability of 1.5% (w/v) pectin solutions to form coherent gels in vitro. Gelation of sorbitol-free formulations was observed at pH 1.2 and in vitro release of acetaminophen from the gels followed diffusion-controlled kinetics; in vitro gelation of these formulations, however, was incomplete at pH 3.0 resulting in poor sustained release characteristics. Inclusion of 10% (w/v) D-sorbitol in the formulations inhibited the in vitro gelation of the 1.5% (w/v) pectin sols and poor sustained release properties were noted from these formulations even at pH 1.2. The bioavailability of acetaminophen from gels formed in the stomach of gastric-acidity controlled rabbits following oral administration of the liquid formulations was not, however, significantly affected either by the inclusion of 10% (w/v) D-sorbitol or increase of pH to 3.6. Visual observation showed in situ gelation of 1.5% (w/v) pectin formulations containing D-sorbitol at pH 4.3 suggesting that normal variations of gastric acidity in the fasting state will have no effect on the bioavailability of acetaminophen when delivered using these formulations.
sieve (JP XIV, No. 6.5, 2.80 mm) over a period of 30 s and the weight of the gel remaining in the sieve was determined (electronic balance, BL-220H, Shimadzu Ltd., Japan).
Measurement of In Vitro Drug Release
The release rates of acetaminophen were measured by using plastic dialysis cells similar to that described previously.
7) The capacity of each half-cell was 4 ml and the surface area of the membranes was 2.67 cm 2 . Sols of 1.5% (w/v) pectin (with and without added D-sorbitol) loaded with 1.0% (w/v) of acetaminophen were placed in the donor compartment. An equal volume of simulated gastric (pH 1.2, 3.0) or intestinal (pH 6.8) fluid (as specified for the JP XIV disintegration test) was placed in the receptor compartment. The donor phase and the aqueous receptor phase were separated by a cellulose membrane (Viskase Sales Co., Chicago, U.S.A., size 36/32). The assembled cell was shaken horizontally at the rate of 60 strokes/min in an incubator. The total volume of the receptor solution was removed at intervals and replaced by fresh release medium. The concentration of acetaminophen in the samples was determined by HPLC as described below.
Gastric Acidity Controlled Rabbits White male rabbits weighing 2.5-3.3 kg were used for the experiment. The pH control of the gastric contents was performed by the method of Takahashi et al. 8) and involved the following steps: each rabbit was fed 100 g/d of special solid diet (CR-3 not containing alfalfa, Clea Japan Inc., Tokyo, Japan) for one week, fasted for 24 h, fed 50 g/d of the special soft diet for 2 d, fed either 20 g of special soft diet containing hydrochloric acid or 20 g of special soft diet containing 2 g of antacid magnesium aluminometasilicate (Spiegel TM , Fuso Pharmaceutical Industries, Ltd., Osaka, Japan) just before the administration experiment. The intragastric pH was measured as follows. The rabbits were anaesthetized with an i.v. injection of pentobarbital (25 mg/kg). A micro pH glass electrode (CM-181, Chemical Instruments Co., Ltd., Tokyo, Japan) was inserted in the stomach, a comparative ceramic electrode (CMR-535, Chemical Instruments Co., Ltd., Tokyo, Japan) was glued to the leg and the intragastric pH was directly measured by pH meter (F-22, Horiba, Ltd., Tokyo, Japan).
In Vivo Drug Release A 1.5% (w/v) pectin sol preparation containing 50 mg/5 ml acetaminophen was administered orally using a stomach sonde needle for rabbits (KN-342, Natume Seisakusho Co., Ltd., Tokyo, Japan). At given intervals, a blood sample was taken from the ear vein and analyzed as described below. The protocols for the animal experiments were previously approved by the Animal Ethics and Research Committee of the Health Sciences University of Hokkaido. The statistical significance of the results was assessed by the Student's t-test and results are presented as the meanϮstandard error of the mean.
Assay of Acetaminophen The plasma samples were separated by centrifugation and assayed by HPLC (Shimadzu LC-10A with a Shimadzu SPD-10A detector at a wavelength of 254 nm). The assay of acetaminophen was based on the methods described by Ameer et al. 9) with minor modifications. To 200 ml of plasma was added 200 ml of water, 100 ml of 2-acetamidophenol solution (100 mg/mg in 20% methanol) as internal standard, and 7 ml of ethyl acetate. The sample was vortex-mixed and centrifuged, after which 5 ml of the organic layer was evaporated to dryness under a nitrogen stream. The residue was reconstituted with 200 ml of 50% methanol, and aliquots of 20 ml were injected onto a 150ϫ 4.6 mm i.d. column, packed with Inertsil-ODS (GL Sciences Inc., Tokyo, Japan). Elution was carried out with acetonitrile-0.1 M sodium acetate buffer (pH 4.0) (15 : 85) at a rate of 0.8 ml/min at 40°C. Figure 1 compares the weight of gel formed from 30 ml solutions of 1.5% (w/v) pectin in the presence and absence of 10% (w/v) D-sorbitol after dialysis in solutions of HCl over the pH range 1.0 to 3.5. The H ϩ ion concentrations at pH 1.0 and 2.0 were sufficiently high to release the complexed calcium ions and cause complete gelation of both formulations. The inclusion of D-sorbitol had an inhibitory effect on gelation at pH 2.5 and 3.0; neither formulation gelled at pH Ͼ 3.0. These findings are in agreement with our previous observations 4) that inclusion of D-sorbitol in the pectin formulations reduced the gel strength presumably because of disruption of the process of chain aggregation. Visual observation showed the formation of well defined cylindrical gels at pH 1.0 and 2.0 (Fig. 2) by both formulations but those formed at pH 2.5 were less structured. Figure 3 compares the in vitro drug release characteristics of 1.5% (w/v) pectin formulations containing 10% (w/v) D-sorbitol with the equivalent sorbitol-free formulation. The receptor solution of the diffusion cell was changed after 1 h from simulated gastric fluid at pH 1.2 or 3.0 to a simulated intestinal fluid at pH 6.8 to mimic gastrointestinal transit at two extremes of gastric acidity in the fasting state.
RESULTS AND DISCUSSION

Effect of pH and D-Sorbitol on Gelation of Pectin Sols
Effect of pH and D-Sorbitol on In Vitro Release of Acetaminophen
In formulations initially exposed to simulated gastric fluid at pH 1.2 the presence of D-sorbitol caused a pronounced increase of release after about 3 h. No such inflection was observed for the sorbitol-free formulation under these conditions. Observation of the contents of the donor cell during release measurements showed that the inflection coincided with a gel to sol transition, i.e. this gel had insufficient strength to withstand the large decrease of hydrogen ion concentration when the pH of the receptor cell was increased to pH 6.8; gels formed in the sorbitol-free formulations retained their integrity throughout the measurement period. The release data were analysed using the Higuchi equation 10) for drug release from semisolid vehicles containing dissolved drug over the whole time period of release, (1) where Q is the amount of drug released per unit surface area from gels of initial drug concentration C 0 in time t. The plot of Q vs. t 1/2 (Fig. 4) was linear for release from the sorbitolfree formulation and a diffusion coefficient, D, of (5.75Ϯ 0.36)ϫ10
Ϫ6 cm 2 /s (nϭ4) was calculated from the gradient. As expected, the Higuchi plot for the formulation containing D-sorbitol showed an inflection at the gel-to-sol transition; a value of D, of (9.02Ϯ0.50)ϫ10
Ϫ6 cm 2 /s (nϭ4) was calculated for the initial 3 h of release. Figure 3 shows that release of drug from formulations initially exposed to simulated gastric fluid at pH 3.0 was much higher than for the equivalent formulation at pH 1.2. The higher release rate in the presence of D-sorbitol again demonstrates the inhibiting effect of this taste masking agent on gelation. Visual observation of the donor cells showed that the formulations were predominantly in sol form throughout the duration of the release period and no attempts were made to determine diffusion coefficients for these formulations.
The Effect of Gastric Acidity and D-Sorbitol on In Vivo Drug Release Plasma drug levels following oral administration of acetaminophen (50 mg/5 ml) from 1.5% (w/v) pectin sols to rabbits with high ( Fig. 5a) and low (Fig.  5b) gastric acidity are compared for sorbitol-free and sorbitol-containing formulations. The area under the plasma concentration-time curve (AUC) and the mean residence time (MRT) obtained from the plasma concentration-time data of each animal using a computer program for model-independent analysis 11) are compared in Table 1 . No significant difference in bioavailability between the two groups of rabbit in either formulation could be detected suggesting that gastric acidity had no measurable effect on the bioavailability of acetaminophen in the gastric pH range investigated. Similarly, the results show no significant influence of 10% (w/v) D-sorbitol on the bioavailability of both formulations. Photographs of the contents of rabbit stomachs of high and low gastric acidity groups after administration of 5 ml of 1.5% (w/v) pectin sols formulated with and without 10% (w/v) D-sorbitol (and containing a marker dye but no drug) show gelation in both groups of rabbits (Fig. 6) . Although gelation of formulations containing D-sorbitol was less effective at the higher pH (pH 4.3) with only 37.6% of the formulation forming recoverable gel compared to 66.5% at pH 0.7, nevertheless the results show that these gels are capable of sustaining release of acetaminophen to a similar extent as those formed in a strongly acidic environment. These findings contrast with the predictions from the in vitro release studies which show large differences in release under conditions of high and low gastric acidity as a consequence of the failure of the pectin formulations to form coherent gels when dialysed against solutions at pH Ͼ2.5. The reason for the difference in gelation characteristics between in vivo and in vitro environments can probably be explained by the presence of calcium in the gastric juice, particularly ionised calcium from gastric interstitial (non-parietal) fluid, 12) which Each value is the meanϮS.E. of 4 determinations. See Table 1 for pH values. would compensate for the lower amount of complexed calcium released at higher pH so promoting in vivo gelation.
CONCLUSION
This study has demonstrated that 1.5% (w/v) pectin sols formulated with a source of calcium in complexed form and containing 10% (w/v) D-sorbitol as a taste masking agent did not form coherent gels in vitro when the pH was above about 2.5, nevertheless they exhibited in situ gelation in the rabbit stomach when the gastric pH was as high as 4.3, presumably because of the presence of residual calcium ions in the stomach. Bioavailability studies indicated similar sustained release characteristics in rabbits of 1.5% (w/v) pectin sols formulated with and without the taste masking agent.
